Category / Product: SERVICES, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Region: Europe

mAbxience CDMO
24.000 l Einwegkapazität für die GMP-Herstellung antikörperähnlicher Moleküle
Compliance: ANVISA (Brazil B-GMP), COFEPRIS, ISO, TITCK (Turkish Health Authorities), ICH, MHRA (UK GMP), ANMAT (Argentina nueva GMP), ISP (Chile BPM), EMA (EU GMP), World Health Organization (GMP / HACCP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: EMA (EU), INVIMA (Colombia), Russian Health Authorities, ANMAT (Argentina), Rest der Welt, COFEPRIS (Mexico), EDE (UAE), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), Turkish Health Authorities, SFDA (Saudi Arabia)
Batch Size: Large, Medium
Region: LATAM
Use: Human
Services: Analytical / QC services, Manufacturing services
Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (D) Dermatologicals, (N) Nervous system, (J) Antiinfectives for systemic use, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Category / Product: BIOLOGICS
Region: LATAM
Services: Development services, Manufacturing services
Compliance: ANMAT (Argentina nueva GMP)
Markets: ANMAT (Argentina), Rest der Welt
Category / Product: BIOLOGICS

CONTENT GROUP
COC Farmaceutici srl: Sitz; Produktionsstätte.
Category / Product: COSMETICS, ANALYTISCHE CRO, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC
Batch Size: Large, Medium
Markets: EMA (EU)
Compliance: ISO, EMA (EU GMP)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs, (R) Respiratory system
Region: Europe

CONTENT GROUP
COC Farmaceutici srl: Handels- und Verwaltungssitz; Produktionsstätte.
Category / Product: COSMETICS, ANALYTISCHE CRO, FDF / DRUG PRODUCTS
Batch Size: Large, Medium
Markets: EMA (EU), MHRA (UK), EDE (UAE), SFDA (Saudi Arabia)
Compliance: ISO
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Region: Europe

Batch Size: Large, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), FDA (cGMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP)
Markets: EMA (EU), Russian Health Authorities, FDA (USA), ANVISA (Brazil), TGA (Australia)
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (S) Sensory organs
Category / Product: ANALYTISCHE CRO, FDF / DRUG PRODUCTS
Region: Europe

mAbxience CDMO
24.000 l Einwegkapazität für die Entwicklung antikörperähnlicher Moleküle und die GMP-Herstellung, von der Zelllinienentwicklung bis zur kommerziellen Arzneimittelsubstanz
Batch Size: Large, Small, Medium
Compliance: TITCK (Turkish Health Authorities), ANVISA (Brazil B-GMP), COFEPRIS, ISO, ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), Health Canada (Canada GMP), MHRA (UK GMP), ANMAT (Argentina nueva GMP), TGA (Australia GMP), Roszdravnadzor (Russia GMP), ECOVADIS, ISP (Chile BPM), French Service-Public (CIR), World Health Organization (GMP / HACCP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: EMA (EU), MHRA (UK), INVIMA (Colombia), MSPAS (Guatemala), Russian Health Authorities, FDA (USA), PMDA (Japan), Health Canada (Canada), ANMAT (Argentina), Rest der Welt, COFEPRIS (Mexico), EDE (UAE), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), Turkish Health Authorities, MFDS (South Korea), SFDA (Saudi Arabia), TGA (Australia)
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services
Use: Human, Veterinary
Therapeutic Areas of Expertise (ATC): (B) Blood and blood forming organs, (D) Dermatologicals, (N) Nervous system, (J) Antiinfectives for systemic use, (R) Respiratory system, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Region: Europe
Category / Product: BIOLOGICS

53Biologics
53Biologics ist ein End-to-End-CDMO für Biologika, das darauf ausgelegt ist, den Fortschritt von der präklinischen bis zur kommerziellen Versorgung voranzutreiben. Dafür sind wir geschaffen.
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Compliance: ISO, FDA (cGMP), World Health Organization (GMP / HACCP), EMA (EU GMP)
Markets: FDA (USA), Health Canada (Canada), ANMAT (Argentina), COFEPRIS (Mexico), ISP (Chile), ANVISA (Brazil), DIGEMID (Peru), MSPAS (Guatemala), INVIMA (Colombia), MHRA (UK), EMA (EU), TGA (Australia)
Services: Development services, Analytical / QC services, Logistics, Manufacturing services, Quality Assurance services, Regulatory services
Use: Human, Veterinary
Region: Europe
Category / Product: BIOLOGICS

InClino
Europäisches Auftragsforschungsunternehmen mit mehr als 20 Jahren Erfahrung in klinischer Forschung und regulatorischen Angelegenheiten. Wir helfen Therapien, Wunder zu bewirken.
Markets: EMA (EU)
Services: Development services, Regulatory services
Therapeutic Areas of Expertise (ATC): (V04) Diagnostic agents, (D) Dermatologicals, (J) Antiinfectives for systemic use, (B) Blood and blood forming organs, (V09-10) Radiopharmaceuticals, (N) Nervous system, (S) Sensory organs, (V06) Nutrients, (V01) Allergens, (R) Respiratory system, (P) Antiparasitic products, insecticides and repellents, (M) Musculoskeletal system, (L) Antineoplastic and immunomodulating agents, (H) Systemic hormonal preparations excl. sex hormones and insulins, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Category / Product: KLINISCHE CRO, SERVICES
Use: Human
Region: Europe

Bilthoven Biologicals BV
GMP-Anlagen für mehrere Produkte für Arzneimittelsubstanzen und Arzneimittelprodukte.
Markets: EMA (EU), MHRA (UK)
Batch Size: Large, Small, Medium
BSL (Biological Safety Level): 1, 2
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Compliance: EMA (EU GMP)
Category / Product: FDF / DRUG PRODUCTS, ANALYTISCHE CRO, BIOLOGICS
Region: Europe

Polpharma API
Integrated CDMO solutions for HP APIs (OEB 6), ADC payload-linkers and oligonucleotides from development to GMP supply.
Compliance: BRCGS, ISO, ICH, FDA (cGMP), DIGEMID, ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, Roszdravnadzor (Russia GMP), IFS, Halal Research Council, PMDA/MHLW (Japan GMP), TGA (Australia GMP), INVIMA, ECOVADIS, ISP (Chile BPM), TITCK (Turkish Health Authorities), French Service-Public (CIR), ANMAT (Argentina nueva GMP), EMA (EU GMP), NMPA (China GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP), SQF (Safe Quality Food), NSF, UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority)
Markets: FDA (USA), EMA (EU), PMDA (Japan), NMPA (China), Health Canada (Canada), MHRA (UK), MFDS (South Korea)
Batch Size: Large, Small, Medium
Services: Development services, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services
Therapeutic Areas of Expertise (ATC): (N) Nervous system, (B) Blood and blood forming organs, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (G) Genito urinary system and sex hormones, (C) Cardiovascular system, (A) Digestive tract and metabolism
Category / Product: PARTICLE ENGINEERING, SERVICES, CHEMICAL-SYNTHETIC, OLIGONUCLEOTIDES
Use: Human
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Region: Europe

Arcinova - A Quotient Sciences Company
Arcinova beschleunigt die Arzneimittelentwicklung von der frühen Entdeckung bis zum Proof of Concept und darüber hinaus.
Compliance: FDA (cGMP), ICH, MHRA (UK GMP), EMA (EU GMP)
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada (Canada), MHRA (UK)
Services: Development services, Logistics, Analytical / QC services, Manufacturing services, Quality Assurance services, Regulatory services, Packaging
Use: Human
Controlled Substances: Lowest potential for abuse, Lower potential for abuse, High potential for abuse & no medical use, Low potential for abuse, Narcotic, High potential for abuse & medical use
Batch Size: Small
OEB (Occupational Exposure Banding): 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 5,000 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
Category / Product: FDF / DRUG PRODUCTS, ANALYTISCHE CRO, CHEMICAL-SYNTHETIC
Region: Europe
Register to unlock the full catalog with contact details and locations.
+163 more facilities
Create free accountSind Sie ein pharmazeutisches Unternehmen und suchen einen zuverlässigen CMO- oder CDMO-Partner, um Ihren Arzneimittelentwicklungsprozess zu beschleunigen? Suchen Sie nicht weiter als MAI CDMO Network. Unsere fortschrittliche Suchplattform verbindet Sie mit einem umfangreichen Netzwerk von qualifizierten Auftragsherstellern und Entwicklungsorganisationen weltweit.
Warum MAI CDMO Network wählen?
So funktioniert MAI CDMO Network
Die wichtigsten Vorteile einer Partnerschaft mit einer CMO/CDMO
Ausgewählte Dienstleistungen
Sind Sie bereit, Ihren idealen CMO/CDMO-Partner zu finden? Jetzt registrieren
Erkunden Sie noch heute unsere Plattform und entdecken Sie, wie MAI CDMO Network Ihnen helfen kann, Ihre Ziele in der Arzneimittelentwicklung zu erreichen.